Publications by authors named "James Breitmeyer"

Claim this Profile
O
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers, Noah Federman, Najat Daw, Peter M Anderson, Lara E Davis, James B Breitmeyer

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman, James B Breitmeyer

Breast Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman, James B Breitmeyer

Breast Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells.
Dongli Liu, Gunnar F Kaufmann, James B Breitmeyer, Kristie-Ann Dickson, Deborah J Marsh

Pharmaceutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Susan P Foy, Stefanie J Mandl, Tracy dela Cruz, Joseph J Cote, Evan J Gordon, James Breitmeyer

Cancer Immunol Immunother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous acetaminophen for pain after major orthopedic surgery: an expanded analysis.
Raymond S Sinatra, Jonathan S Jahr, Lowell Reynolds, Scott B Groudine, Mike A Royal, James B Breitmeyer

Pain Pract· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of intravenous acetaminophen in the elderly after major orthopedic surgery: subset data analysis from 3, randomized, placebo-controlled trials.
Jonathan S Jahr, James B Breitmeyer, Christine Pan, Mike A Royal, Robert Y Ang

Am J Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever.
W Frank Peacock, James B Breitmeyer, Christine Pan, William B Smith, Mike A Royal

Acad Emerg Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the literature on the effects of acetaminophen on pregnancy outcome.
Anthony R Scialli, Robert Ang, James Breitmeyer, Mike A Royal

Reprod Toxicol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood asthma and use during pregnancy of acetaminophen. A critical review.
Anthony R Scialli, Robert Ang, James Breitmeyer, Mike A Royal

Reprod Toxicol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
Steven J Wininger, Howard Miller, Harold S Minkowitz, Mike A Royal, Robert Y Ang, James B Breitmeyer

Clin Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.
Julie A Bowles, Siao-Yi Wang, Brian K Link, Barrett Allan, Gregory Beuerlein, James B Breitmeyer

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis